Literature DB >> 21115796

Carotenoid-related alteration of cell membrane fluidity impacts Staphylococcus aureus susceptibility to host defense peptides.

Nagendra N Mishra1, George Y Liu, Michael R Yeaman, Cynthia C Nast, Richard A Proctor, James McKinnell, Arnold S Bayer.   

Abstract

Carotenoid pigments of Staphylococcus aureus provide integrity to its cell membrane (CM) and limit oxidative host defense mechanisms. However, the role of carotenoids in staphylococcal resistance to nonoxidative host defenses has not been characterized. The current study examined the relationship among CM carotenoid content, membrane order, and in vitro susceptibility to daptomycin or to prototypic neutrophil-derived, platelet-derived, or bacterium-derived cationic antimicrobial peptides (human neutrophil defensin-1 [hNP-1], platelet microbicidal proteins [PMPs], or polymyxin B, respectively). A previously characterized methicillin-susceptible Staphylococcus aureus (MSSA) isogenic clinical strain set was used, including a parental isolate with an intact carotenoid biosynthetic operon (crtOPQMN) containing the crtM gene encoding early steps in staphyloxanthin biosynthesis, a crtM deletion mutant, and a crtMN multicopy plasmid-complemented variant. Compared to the parental and crtM knockout strains, the crtMN-complemented strain exhibited (i) increased carotenoid production, (ii) increased CM rigidity (P < 0.001), and (iii) uniformly reduced susceptibility to killing by the above-mentioned range of cationic peptides (statistically significant for hNP-1 [20 μg/ml]; P = 0.0037). There were no significant differences in phospholipid composition and asymmetry, fatty acid profiles, surface charge, or cell wall thickness among the strain set. Collectively, these data support the concept that carotenoid biosynthesis can contribute to the ability of S. aureus to subvert nonoxidative host defenses mediated by cationic peptides, potentially by increasing target membrane rigidity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21115796      PMCID: PMC3028772          DOI: 10.1128/AAC.00680-10

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  32 in total

1.  CspA regulates pigment production in Staphylococcus aureus through a SigB-dependent mechanism.

Authors:  Samuel Katzif; Eun-Hee Lee; Anthony B Law; Yih-Ling Tzeng; William M Shafer
Journal:  J Bacteriol       Date:  2005-12       Impact factor: 3.490

2.  Low-level resistance of Staphylococcus aureus to thrombin-induced platelet microbicidal protein 1 in vitro associated with qacA gene carriage is independent of multidrug efflux pump activity.

Authors:  A S Bayer; L I Kupferwasser; M H Brown; R A Skurray; S Grkovic; T Jones; K Mukhopadhay; M R Yeaman
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

3.  In vitro susceptibility of Staphylococcus aureus to thrombin-induced platelet microbicidal protein-1 (tPMP-1) is influenced by cell membrane phospholipid composition and asymmetry.

Authors:  Kasturi Mukhopadhyay; William Whitmire; Yan Q Xiong; Jaime Molden; Tiffanny Jones; Andreas Peschel; Petra Staubitz; Jill Adler-Moore; Peter J McNamara; Richard A Proctor; Michael R Yeaman; Arnold S Bayer
Journal:  Microbiology       Date:  2007-04       Impact factor: 2.777

4.  Carotenoid-membrane interactions in liposomes: effect of dipolar, monopolar, and nonpolar carotenoids.

Authors:  Anna Wisniewska; Justyna Widomska; Witold K Subczynski
Journal:  Acta Biochim Pol       Date:  2006-09-10       Impact factor: 2.149

5.  Effects of polar carotenoids on the shape of the hydrophobic barrier of phospholipid bilayers.

Authors:  A Wisniewska; W K Subczynski
Journal:  Biochim Biophys Acta       Date:  1998-01-19

6.  The cytoplasmic membrane is a primary target for the staphylocidal action of thrombin-induced platelet microbicidal protein.

Authors:  S P Koo; M R Yeaman; C C Nast; A S Bayer
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

7.  Structure and biosynthesis of staphyloxanthin from Staphylococcus aureus.

Authors:  Alexandra Pelz; Karsten-Peter Wieland; Karsten Putzbach; Petra Hentschel; Klaus Albert; Friedrich Götz
Journal:  J Biol Chem       Date:  2005-07-14       Impact factor: 5.157

8.  Staphyloxanthin plays a role in the fitness of Staphylococcus aureus and its ability to cope with oxidative stress.

Authors:  Alexandra Clauditz; Alexandra Resch; Karsten-Peter Wieland; Andreas Peschel; Friedrich Götz
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

9.  Correlation between Reduced Daptomycin Susceptibility and Vancomycin Resistance in Vancomycin-Intermediate Staphylococcus aureus.

Authors:  Longzhu Cui; Eiji Tominaga; Hui-Min Neoh; Keiichi Hiramatsu
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

10.  Functional interrelationships between cell membrane and cell wall in antimicrobial peptide-mediated killing of Staphylococcus aureus.

Authors:  Yan Q Xiong; Kasturi Mukhopadhyay; Michael R Yeaman; Jill Adler-Moore; Arnold S Bayer
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

View more
  95 in total

Review 1.  Mechanisms of drug resistance: daptomycin resistance.

Authors:  Truc T Tran; Jose M Munita; Cesar A Arias
Journal:  Ann N Y Acad Sci       Date:  2015-10-23       Impact factor: 5.691

2.  Impact of Bacterial Membrane Fatty Acid Composition on the Failure of Daptomycin To Kill Staphylococcus aureus.

Authors:  Rym Boudjemaa; Clément Cabriel; Florence Dubois-Brissonnet; Nicolas Bourg; Guillaume Dupuis; Alexandra Gruss; Sandrine Lévêque-Fort; Romain Briandet; Marie-Pierre Fontaine-Aupart; Karine Steenkeste
Journal:  Antimicrob Agents Chemother       Date:  2018-06-26       Impact factor: 5.191

3.  Prolonged Exposure to β-Lactam Antibiotics Reestablishes Susceptibility of Daptomycin-Nonsusceptible Staphylococcus aureus to Daptomycin.

Authors:  Rachel E Jenson; Sarah L Baines; Benjamin P Howden; Nagendra N Mishra; Sabrina Farah; Cassandra Lew; Andrew D Berti; Sanjay K Shukla; Arnold S Bayer; Warren E Rose
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

4.  In Vitro Anticancer Activity of Staphyloxanthin Pigment Extracted from Staphylococcus gallinarum KX912244, a Gut Microbe of Bombyx mori.

Authors:  Delicia Avilla Barretto; Shyam Kumar Vootla
Journal:  Indian J Microbiol       Date:  2018-03-16       Impact factor: 2.461

Review 5.  Bacterial strategies of resistance to antimicrobial peptides.

Authors:  Hwang-Soo Joo; Chih-Iung Fu; Michael Otto
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2016-05-26       Impact factor: 6.237

6.  Inactivation of the exogenous fatty acid utilization pathway leads to increased resistance to unsaturated fatty acids in Staphylococcus aureus.

Authors:  Christina N Krute; Miranda J Ridder; Nichole A Seawell; Jeffrey L Bose
Journal:  Microbiology (Reading)       Date:  2018-12-19       Impact factor: 2.777

7.  Correlation of cell membrane lipid profiles with daptomycin resistance in methicillin-resistant Staphylococcus aureus.

Authors:  Nagendra N Mishra; Arnold S Bayer
Journal:  Antimicrob Agents Chemother       Date:  2012-12-17       Impact factor: 5.191

8.  Role of SigB and Staphyloxanthin in Radiation Survival of Staphylococcus aureus.

Authors:  Miri K Pannu; Deborah A Hudman; Neil J Sargentini; Vineet K Singh
Journal:  Curr Microbiol       Date:  2018-10-23       Impact factor: 2.188

9.  Fatty acids regulate stress resistance and virulence factor production for Listeria monocytogenes.

Authors:  Yvonne Sun; Brian J Wilkinson; Theodore J Standiford; Henry T Akinbi; Mary X D O'Riordan
Journal:  J Bacteriol       Date:  2012-07-27       Impact factor: 3.490

10.  Evaluation of the novel combination of high-dose daptomycin plus trimethoprim-sulfamethoxazole against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus using an in vitro pharmacokinetic/pharmacodynamic model of simulated endocardial vegetations.

Authors:  Molly E Steed; Brian J Werth; Cortney E Ireland; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.